Chondroxide gel 5% 30g

Description

Composition
Active substance:
100 g of gel contains
Chondroitin sulfate – 5 g
Excipients:
Dimethyl sulfoxide, propylene glycol, isopropanol, ethanol (ethyl alcohol 95%), sodium bisulfite (sodium metabisulfite), Nipagin, Nipasol, carbopol, orange flavoring, identical to natural, purified water – 100 g
Description:
Colorless or yellowish color transparent gel with a fruity smell
Product form:
Gel for external use 5% of the aluminum tubes in 30, one in the tube together with instructions for use of the drug in a pile of cardboard.
Contraindications
Hypersensitivity to the drug. Damage to the skin in the area of ​​drug application.
Indications
Degenerative-dystrophic diseases of peripheral joints and spine: the treatment and prevention of osteoarthritis, degenerative disc disease of the spine.
Interaction with other drugs
Cases interaction or incompatibility with other drugs is not known.
Overdose
No cases of overdose were reported Hondroksid® gel.
pharmachologic effect
Pharmacological group:
Tissue regeneration stimulator.
Pharmacodynamics:
Hondroksid® gel has a combined effect: slows the progression of osteoarthritis and osteoarthritis; providing analgesic effects; It possesses anti-inflammatory action; It stimulates the restoration of articular cartilage; improves joint mobility; It reduces swelling of joints. With the optimal combination of gel components marked mutual enhancement of their analgesic and anti-inflammatory effects. Use of the drug Hondroksid® gel allows to reduce the dose received NSAIDs. Hondroksid® comprises a natural component of chondroitin sulfate (high molecular weight mucopolysaccharide), which participates in the construction of the cartilage. Chondroitin sulfate: improves calcium and phosphorus metabolism in cartilage; reduces the activity of enzymes that destroy cartilage; inhibits degeneration processes (destruction) cartilage; It stimulates the synthesis of glycosaminoglycans; It prevents the collapse of the connective tissue. This leads to a decrease in pain and an increase in the mobility of the affected joints.
Pharmacokinetics:
Hondroksid® gel is well absorbed. In accordance with the data obtained in experimental studies in mice using radiolabeled ZN- chondroitin sulfate, chondroitin sulfate absorbability rate is 14%. Dimegilsulfoksid promotes better penetration of chondroitin sulfate through cell membranes deep into the tissues. Chondroitin sulfate after application to the skin Hondroksid® gel rapidly and selectively enters into the joint with achieving maximum concentration after 30 minutes and subsequent excretion biphasic preparation of cartilaginous tissue. Completion rapid elimination phase occurs after 1 hour after application. The retention time of the drug in the joint is 5 hours.
Pregnancy and breast-feeding
During pregnancy and breastfeeding period, the drug is used only after consulting a doctor and with care, the duration of treatment determined by the doctor.
Conditions of supply of pharmacies
Without recipe.
side effects
Allergic reactions.
special instructions
Avoid exposure of the drug to the mucous membranes and open wounds. In contact with skin or clothing, the gel is washed off easily with water, leaving no trace. Do not use the drug without consulting a doctor as a child.
Hondroksid® gel does not cause sedation, psychomotor disturbances, and does not affect the patient’s ability to engage in potentially hazardous activities that require attention and speed of mental and motor responses.
Storage conditions
The reach of children at a temperature not higher than 25 ° C.
Keep out of the reach of children.
Dosing and Administration
Outwardly.
Hondroksid® gel applied 2-3 times daily to the skin over the hearth lesion and rubbed in for 2-3 minutes until completely absorbed. The course of treatment – from 2-3 weeks to 2-3 months. If necessary – repeat the treatment.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist